A randomized, double-blind, parallel study to evaluate the dose-response of three different vitamin D treatment schemes on the 25-hydroxyvitamin D serum concentration in patients with vitamin D deficiency

Nutrients

Volumn 7, Issue 7, 2015, Pages 5413-5422

  Schleck, Marie Louise ^a   Souberbielle, Jean Claude ^b   Jandrain, Bernard ^c   Da Silva, Stéphani ^d   De Niet, Sophie ^d   Vanderbist, Francis ^d   Scheen, André ^a   Cavalier, Etienne ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Department of Clinical Pharmacology   (Belgium)

^d Laboratoires SMB SA   (Belgium)

Author keywords

Randomized double blind trial; Safety; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PHOSPHATE; PLACEBO; 25-HYDROXYVITAMIN D; VITAMIN; VITAMIN D;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG SAFETY; FEMALE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 84936943658     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7075227     Document Type: Article

References (15)

1. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266–281.
2. Ross, A.C.; Manson, J.E.; Abrams, S.A.; Aloia, J.F.; Brannon, P.M.; Clinton, S.K.; Durazo-Arvizu, R.A.; Gallagher, J.C.; Gallo, R.L.; Jones, G.; et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J. Clin. Endocrinol. Metab. 2011, 96, 53–58.
3. Holick, M.F.; Binkley, N.C.; Bischoff-Ferrari, H.A.; Gordon, C.M.; Hanley, D.A.; Heaney, R.P.; Murad, M.H.; Weaver, C.M. Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J. Clin. Endocrinol. Metab. 2012, 97, 1153–1158.
4. Bruyère, O.; Slomian, J.; Beaudart, C.; Buckinx, F.; Cavalier, E.; Gillain, S.; Petermans, J.; Reginster, J.Y. Prevalence of vitamin D inadequacy in European women aged over 80 years. Arch. Gerontol. Geriatr. 2014, 59, 78–82.
5. Weng, F.L.; Shults, J.; Leonard, M.B.; Stallings, V.A.; Zemel, B.S. Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents. Am. J. Clin. Nutr. 2007, 86, 150–158.
6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO Clinical Practice Guidelines for the Diagnosis, Evaluation, Prevention and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int. 2009.
7. Eastell, R.; Brandi, M.L.; Costa, A.G.; Amour, P.D.; Shoback, D.M.; Thakker, R.V. Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop. J. Clin. Endocrinol. Metab. 2014, 99, 3570–3579.
8. Rizzoli, R.; Boonen, S.; Brandi, M.-L.; Bruyère, O.; Cooper, C.; Kanis, J.A.; Kaufman, J.-M.; Ringe, J.D.; Weryha, G.; Reginster, J.-Y. Vitamin D supplementation in elderly or postmenopausal women: A 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr. Med. Res. Opin. 2013, 29, 305–313.
9. Adams, J.S.; Hewison, M. Update in vitamin D. J. Clin. Endocrinol. Metab. 2010, 95, 471–478.
10. Cavalier, E.; Faché, W.; Souberbielle, J.C. A randomised, double-blinded, placebo-controlled, parallel study of vitamin D3 supplementation with different schemes based on multiples of 25,000 IU doses. Int. J. Endocrinol. 2013.
11. Heaney, R.P.; Davies, K.M.; Chen, T.C.; Holick, M.F.; Barger-Lux, M.J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am. J. Clin. Nutr. 2003, 77, 204–210.
12. Autier, P.; Gandini, S.; Mullie, P. A systematic review: Influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J. Clin. Endocrinol. Metab. 2012, 97, 2606–2613.
13. McKenna, M.J.; Murray, B.F. Vitamin D dose response is underestimated by Endocrine Society’s Clinical Practice Guideline. Endocr. Connect. 2013, 2, 87–95.
14. Ilahi, M.; Armas, L.A.G.; Heaney, R.P. Pharmacokinetics of a single, large dose of cholecalciferol. Am. J. Clin. Nutr. 2008, 87, 688–691.
15. Roth, D.E.; Al Mahmud, A.; Raqib, R.; Black, R.E.; Baqui, A.H. Pharmacokinetics of a single oral dose of vitamin D3 (70,000 IU) in pregnant and non-pregnant women. Nutr. J. 2012, 11, 114.